Novanta (MEX:NOVTN) Cyclically Adjusted PB Ratio: 8.06 (As of Aug. 16, 2026) — 26% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:NOVTN Novanta Inc MEX:NOVTN
83 GF Score
Price MXN2,472.83
GF Value MXN2,549.60
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Novanta Cyclically Adjusted PB Ratio?

Novanta MEX:NOVTN 83 Cyclically Adjusted PB Ratio is 8.06 as of Aug. 16, 2026, which is 26% below its 10-year median of 10.88. GuruFocus rates MEX:NOVTN with a GF Score™ of 83/100 and a GF Value™ of MXN2,549.60 (Fairly Valued). The stock has 7 warning signs investors should review. Among 1,962 Hardware companies, Novanta ranks worse than 89.65% on this metric.

As of today (2026-08-16), Novanta's current share price is MXN2472.83. Novanta's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was MXN306.72. Novanta's Cyclically Adjusted PB Ratio for today is 8.06.

The historical rank and industry rank for Novanta's Cyclically Adjusted PB Ratio or its related term are showing as below:

MEX:NOVTN' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.37   Med: 10.88   Max: 18.38
Current: 9.1

During the past years, Novanta's highest Cyclically Adjusted PB Ratio was 18.38. The lowest was 1.37. And the median was 10.88.

MEX:NOVTN's Cyclically Adjusted PB Ratio is ranked worse than
89.65% of 1962 companies
in the Hardware industry
Industry Median: 2.115 vs MEX:NOVTN: 9.10

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Novanta's adjusted book value per share data for the three months ended in Jun. 2026 was MXN745.864. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN306.72 for the trailing ten years ended in Jun. 2026.

Shiller PE for Stocks: The True Measure of Stock Valuation


Novanta  (MEX:NOVTN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Novanta Cyclically Adjusted PB Ratio Related Terms


Novanta Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Novanta's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novanta Cyclically Adjusted PB Ratio Chart

Novanta Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.31 11.77 13.14 10.70 7.30

Novanta Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.46 6.39 7.30 6.83 8.86

MEX:NOVTN vs VNT, ITRI, BMI: Cyclically Adjusted PB Ratio Comparison

For the Scientific & Technical Instruments subindustry, Novanta's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novanta Cyclically Adjusted PB Ratio vs Hardware Industry

For the Hardware industry and Technology sector, Novanta's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Novanta's Cyclically Adjusted PB Ratio falls into.


MEX:NOVTN
83GF Score
Novanta Inc MEX:NOVTN
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novanta Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Novanta's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2472.83/306.72
=8.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novanta's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Novanta's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=745.864/333.9520*333.9520
=745.864

Current CPI (Jun. 2026) = 333.9520.

Novanta Quarterly Data

Book Value per Share CPI Adj_Book
201609 144.403 241.428 199.743
201612 154.888 241.432 214.243
201703 160.349 243.801 219.642
201706 159.195 244.955 217.034
201709 162.230 246.819 219.501
201712 176.863 246.524 239.586
201803 166.885 249.554 223.325
201806 183.832 251.989 243.626
201809 192.684 252.439 254.902
201812 207.266 251.233 275.509
201903 210.453 254.202 276.478
201906 212.116 256.143 276.551
201909 226.669 256.759 294.816
201912 224.463 256.974 291.702
202003 275.794 258.115 356.825
202006 283.576 257.797 367.346
202009 283.519 260.280 363.769
202012 269.735 260.474 345.825
202103 275.052 264.877 346.780
202106 276.563 271.696 339.934
202109 288.857 274.310 351.662
202112 300.378 278.802 359.796
202203 298.349 287.504 346.549
202206 300.541 296.311 338.719
202209 305.595 296.808 343.839
202212 315.326 296.797 354.801
202303 301.080 301.836 333.116
202306 299.726 305.109 328.060
202309 313.674 307.789 340.337
202312 319.190 306.746 347.500
202403 315.230 312.332 337.051
202406 358.283 314.175 380.837
202409 406.895 315.301 430.964
202412 432.747 315.605 457.904
202503 437.877 319.799 457.256
202506 419.498 322.561 434.312
202509 410.156 324.800 421.713
202512 663.414 324.054 683.678
202603 663.878 330.213 671.395
202606 745.864 333.952 745.864

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

What does a Cyclically Adjusted PB Ratio of 8.06 mean?
Novanta (MEX:NOVTN) has a Cyclically Adjusted PB Ratio of 8.06 as of Aug. 16, 2026. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Novanta and its competitors. This is 26% below median its historical median of 10.88. Over the past decade, Novanta's Cyclically Adjusted PB Ratio has ranged from 1.37 to 18.38. According to the industry distribution chart, Novanta ranks #1759 out of 1962 companies in the Hardware industry, placing it in the top 89.7%.
Is Novanta's Cyclically Adjusted PB Ratio too high?
Novanta's current Cyclically Adjusted PB Ratio of 8.06 is 26% below median its 10-year median of 10.88. Over the past 10 years, this metric has ranged from a low of 1.37 to a high of 18.38. The Hardware industry median Cyclically Adjusted PB Ratio is 2.12. Novanta's value of 8.06 is 281.1% above this industry median. Based on the distribution chart, Novanta ranks #1759 out of 1962 companies in the Hardware industry, which is in the bottom quartile relative to peers. Overall, Novanta has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Novanta's Cyclically Adjusted PB Ratio compare to VNT and ITRI?
According to the Hardware industry distribution chart, Novanta ranks #1759 out of 1962 companies for Cyclically Adjusted PB Ratio. This places Novanta in the lower half of its industry. The industry median Cyclically Adjusted PB Ratio is 2.12. Novanta's value of 8.06 is 281.1% above this benchmark. Historically, Novanta's own Cyclically Adjusted PB Ratio has ranged from 1.37 to 18.38 over the past decade. While the company's 10-year median is 10.88 vs. the industry median of 2.12, Novanta has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PB Ratio for a Hardware company?
The median Cyclically Adjusted PB Ratio among Hardware companies is 2.12, based on 1,962 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Novanta's current Cyclically Adjusted PB Ratio of 8.06 is 281.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PB Ratio mean?
A high Cyclically Adjusted PB Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Novanta and its competitors. For the Hardware industry, the median Cyclically Adjusted PB Ratio is 2.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novanta's current Cyclically Adjusted PB Ratio is 8.06, which is 26% below median its own 10-year median of 10.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novanta stock overvalued right now?
Based on GuruFocus' analysis, Novanta (MEX:NOVTN) is currently considered Fairly Valued. The stock's GF Value™ is MXN2,549.60, compared to a current price of MXN2,472.83 — trading 3% below its estimated fair value. The current Cyclically Adjusted PB Ratio is 8.06, which is 26% below median its 10-year median of 10.88 and 281.1% above the Hardware industry median of 2.12. Novanta's overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PB Ratio calculated?
Cyclically Adjusted PB Ratio is calculated from a company's financial statements. For Novanta (MEX:NOVTN), the current Cyclically Adjusted PB Ratio is 8.06 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novanta (MEX:NOVTN) Overvalued in 2026?

Based on GuruFocus' analysis, Novanta stock appears to be undervalued. The current stock price of MXN2,472.83 is trading 3% below its estimated GF Value™ of MXN2,549.60. GuruFocus considers Novanta to be Fairly Valued.

Key valuation signals for MEX:NOVTN:

  • Cyclically Adjusted PB Ratio: 8.06 (26% below median its 10-year median of 10.88)
  • GF Value™: MXN2,549.60 vs. price of MXN2,472.83 (3% below fair value)
  • GF Score™: 83/100 with 7 warning signs
  • Industry Position: 281.1% above the Hardware median (#1759 of 1962)

No single metric tells the full story. See the MEX:NOVTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Novanta Business Description

Other Exchanges NOVT:USA0VAG:UK1GSN:Germany
Address 125 Middlesex Turnpike, Bedford, MA, USA, 01730
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
83GF Score

Get the complete analysis for MEX:NOVTN

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,472.83
Price
MXN2,549.60
GF Value